BISPHAM BARBARA HARLIN (See Remarks) received a stock award from CRESCENT BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 12/17/2025ACC: 0001628280-25-057669
Officer· See Remarks
Since Jun 2025
+90.61K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
90.61K acquired
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+12.42K
Price / share
—
Trade value
—
% of position
New position
12/15/2025
0.00→12.42K
Ordinary Shares
Direct
Shares
+6K
Price / share
—
Trade value
—
% of position
48.3%
12/15/2025
12.42K→18.42K
Total
Net shares
+18.42K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/15/2025 | A · Award | +12.42K | — | — | New position | 0.00 | 12.42K |
| Ordinary Shares Direct | 12/15/2025 | A · Award | +6K | — | — | 48.3% | 12.42K | 18.42K |
| Total | +18.42K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
72.19K shares
Shares
+72.19K
Strike price
13.21
Held after
72.19K
Exercisable
—
12/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares72.19K shares | 12/15/2025 | A · Award | +72.19K | 13.21 | — | 72.19K |